SCHIZOPHRENIA ADVISOR

Schizophrenia Advisor

Feature

Identifying the Clinical Determinants of Fever in Clozapine Treatment

Investigators found data that showed in patients who were treated with clozapine, the risk of infection was higher compared with patients who were treated with other antipsychotics.
Improving Treatment Adherence in Schizophrenia: Long-Acting Injectables

Psychiatrists give insight into managing treatment adherence in schizophrenia.
Implications of Menopause in Schizophrenia Treatment

Investigators posit that endogenous estrogen may have a protective effect against schizophrenia.
Is Placebo Use Questionable in Schizophrenia Relapse Studies?

Researchers weigh in on the use of placebo-controlled trials in schizophrenia.
Suicide Prevention in Schizophrenia, Obstacles and Awareness

Younger age is associated with being a risk for suicide in patients with schizophrenia, due to the onset of the disease more than age, according to researchers.

Journal Articles

Whitton AE, Green AI, Pizzagalli DA, Roth RM, Williams JM, Brunette MF. Potent dopamine D₂ antagonists block the reward-enhancing effects of nicotine in smokers with schizophrenia [published online January 22, 2019]. Schizophr Bull. doi: 10.1093/schbul/sby185

Gomes FV, Zhu X, Grace A, Stress during critical periods of development and risk for schizophrenia [published online January 30, 2019]. Schizophr Res. doi: 10.1016/j.schres.2019.01.030

Zhuo C, Jiang D, Liu C, et al. Understanding auditory verbal hallucinations in healthy individuals and individuals with psychiatric disorders [published online February 19, 2019]. Psychiatry Res. doi: 10.1016/j.psychres.2019.02.040

Related Links

American Psychiatric Association
https://www.psychiatry.org/

Schizophrenia International Research Society
https://schizophreniaresearchsociety.org/

The Brain & Behavior Research Foundation
www.bbrfoundation.org/research/schizophrenia

Patient Education Materials

Next post in Schizophrenia Advisor